Cita APA

Shofer, S., Beyea, M., Li, S., Bastian, L. A., Wahidi, M. M., Kelley, M., & Lipkus, I. M. (2014). Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Publishing Group.

Chicago Style Citation

Shofer, Scott, Matthew Beyea, Sufeng Li, Lori A. Bastian, Momen M. Wahidi, Michael Kelley, i Isaac M. Lipkus. Feasibility of Using an Epigenetic Marker of Risk for Lung Cancer, Methylation of P16, to Promote Smoking Cessation Among US Veterans. BMJ Publishing Group, 2014.

Cita MLA

Shofer, Scott, et al. Feasibility of Using an Epigenetic Marker of Risk for Lung Cancer, Methylation of P16, to Promote Smoking Cessation Among US Veterans. BMJ Publishing Group, 2014.